| Market Capitalization (Millions $) |
250 |
| Shares
Outstanding (Millions) |
185 |
| Employees |
96 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-213 |
| Cash Flow (TTM) (Millions $) |
23 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Neumora Therapeutics Inc is a pharmaceutical company that specializes in the development of innovative therapies and treatments for respiratory diseases. The company is focused on finding new approaches to address the unmet medical needs of patients suffering from conditions such as chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis.
Neumora Therapeutics aims to improve patients' quality of life by developing novel drug candidates that target specific mechanisms and pathways involved in respiratory diseases. The company's research and development efforts involve identifying and testing new molecules, conducting preclinical and clinical trials, and seeking regulatory approvals for their products.
With a team of experienced scientists, researchers, and healthcare professionals, Neumora Therapeutics is dedicated to advancing the field of respiratory medicine. They collaborate with leading academic institutions and other industry partners to accelerate the discovery and development process.
In addition to drug development, Neumora Therapeutics also prioritizes patient education and engagement. They are committed to increasing awareness about respiratory diseases, their symptoms, and available treatment options, thereby contributing to better care and management of these conditions.
Overall, Neumora Therapeutics Inc is a biopharmaceutical company focused on developing innovative therapies for respiratory diseases with the goal of improving the lives of patients.
Company Address: 260 Arsenal Place, Watertown 2472 MA
Company Phone Number: 760-0900 Stock Exchange / Ticker: NASDAQ NMRA
|
1.56%